Skip to Content

UPSHER-SMITH 200 mg (Topiramate extended-release 200 mg)

Pill imprint UPSHER-SMITH 200 mg has been identified as Topiramate extended-release 200 mg.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; borderline personality disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate extended-release 200 mg UPSHER-SMITH 200 mg
Discount Card Promo
Topiramate extended-release
Imprint:
UPSHER-SMITH 200 mg
Strength:
200 mg
Color:
Brown / Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Upsher-Smith Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide